Multivitamin Recall Affects 25 States: FDA Outlines Risk Levels

Overview of the Recall

A chewable multivitamin product has been recalled across 25 states after a U.S. Food and Drug Administration (FDA) inspection revealed that it contained lower-than-intended levels of Vitamin D. The recall stems from findings regarding Multivitamin with Fluoride Chewable Tablets, Grape Flavor, manufactured by Winder Laboratories, LLC, based in Winder, Georgia.

Details of the Affected Product

Two variations of the multivitamin are part of this recall:

0.25 mg fluoride in bottles of 100 tablets with NDC 75826-169-10 and UPC 3 15826 16910 2
1.0 mg fluoride, also in 100-tablet bottles, with NDC 75826-171-10 and UPC 3 15826 17110 5

Each product type is affected by the recall, prompting concern among consumers who rely on these vitamins for their health.

Health Implications

Vitamin D is crucial for bone health, facilitating calcium absorption and bolstering the immune system. Insufficient levels may lead to adverse health outcomes, particularly for the elderly and children who are at higher risk of developing complications from vitamin deficiencies.

Recall Procedures

The voluntary recall was initiated on October 27, 2025, after findings showed that the products did not meet FDA specifications for potency.

Categories and Classifications

The FDA classified this recall as a Class III, which is the lowest risk category. This classification signifies that while the lessened potency does not pose a significant health risk, it requires corrective measures to ensure compliance.

Distribution and State Impact

The recall affects a significant amount of product—specifically:

422 cases of the 0.25 mg product
210 cases of the 1.0 mg product

Each case contains 12 bottles of the respective product. The recall has reportedly spread across various states and territories including:

Alabama
California
Florida
Texas
New York

Throughout this distribution, health groups urge consumers to check their medications for the recalled products and properly dispose of them if found.

Next Steps for Consumers

If you suspect you have purchased the affected multivitamin tablets, you should:

Check the product packaging for the listed NDC and UPC
Contact Winder Laboratories for further instructions on returning the product
Consult your healthcare provider if you have been consuming these multivitamins regularly

Conclusion

While the FDA's classification indicates minimal immediate risk, this incident underscores the importance of consumer awareness regarding dietary supplements. Companies are mandated to uphold strict standards of quality, and any failure has implications for public health.

Key Facts

Product Recall: A chewable multivitamin has been recalled across 25 states due to insufficient Vitamin D levels.
Manufacturer: The affected product is manufactured by Winder Laboratories, LLC, based in Winder, Georgia.
Affected Variations: The recall includes two variations: 0.25 mg fluoride and 1.0 mg fluoride, both in bottles of 100 tablets.
FDA Classification: The FDA classified the recall as a Class III, indicating minimal health risk.
Recall Initiation Date: The recall was initiated on October 27, 2025.
Health Implications: Insufficient Vitamin D levels can lead to adverse health outcomes, especially for the elderly and children.
Recall Scope: 422 cases of the 0.25 mg and 210 cases of the 1.0 mg product are affected.
Consumer Guidance: Consumers should check product packaging for NDC and UPC, contact Winder Laboratories for returns, and consult their healthcare provider.

Background

The recall reflects concerns about the safety and compliance of dietary supplements, highlighting the importance of consumer awareness regarding product quality.

Quick Answers

What caused the multivitamin recall?: The recall was caused by lower-than-intended levels of Vitamin D found during an FDA inspection.
How many states are affected by the multivitamin recall?: The multivitamin recall affects 25 states.
Who manufactured the recalled multivitamins?: Winder Laboratories, LLC manufactured the recalled multivitamins.
What should consumers do if they have the recalled product?: Consumers should check the product packaging, contact Winder Laboratories for returns, and consult their healthcare provider.
What are the two variations of the recalled multivitamins?: The recalled multivitamins include a 0.25 mg fluoride version and a 1.0 mg fluoride version.
What is the FDA's classification of this recall?: The FDA classified this recall as a Class III, which indicates minimal risk.
What health issues may arise from insufficient Vitamin D?: Insufficient Vitamin D levels may lead to adverse health outcomes, particularly for the elderly and children.
When was the recall initiated?: The recall was initiated on October 27, 2025.

Frequently Asked Questions

What is a Class III recall?

A Class III recall is assigned when the use of a product is not likely to cause adverse health consequences, but it still violates FDA regulations.

How can consumers identify the affected products?

Consumers can identify the affected products by checking the NDC and UPC on the packaging.

Where were the recalled multivitamins distributed?

The recalled multivitamins were distributed across various states, including Alabama, California, and Florida.

Source reference: https://www.newsweek.com/multivitamin-recall-update-fda-risk-level-11677945